Skip to main content

Application of BIOMED-2 clonality assays to formalin-fixed paraffin embedded follicular lymphoma specimens: superior performance of the IGK assays compared to IGH for suboptimal specimens.

Halldórsdóttir AM, Zehnbauer BA, Burack WR

Publication: Leuk Lymphoma (2007) • Vol 48 • Page 1338-43PMID: 17613763View on PubMed

Purpose

The purpose of this paper was to compare the clonality determination rates using the different BIOMED-2 immunoglobin (IG) assays in formalin-fixed paraffin-embedded (FFPE) follicular lymphoma (FL) and small lymphocytic lymphoma/chronic lymphocytic leukemia (SLL/CLL) specimens.

Conclusion

The two BIOMED-2 IG kappa (IGK) assays were the most successful in establishing clonality in FFPE FL specimens followed by the BIOMED-2 IG lambda (IGL) assays. The BIOMED-2 IG H (IGH) framework assay was slightly less successful at establishing clonality than the BIOMED-2 IGL assay in FFPE FL specimens; however, clonality establishment using the BIOMED-2 IGH assay was more successful in FFPE SLL/CLL specimens and in fresh/frozen FL specimens than in FFPE FL specimens.

Studies (1)

Purpose

The purpose of this study was to compare clonality determination rates using the different BIOMED-2 IG assays in FFPE FL and SLL/CLL specimens and to determine the effects of preservation method on the rate of success of the BIOMED-2 IGH framework assays.

Summary of Findings

Using all three BIOMED-2 IGH framework assays, clonality was established in 14 of 40 FFPE FL specimens, and 29 of 32 FFPE SLL/CLL specimens. Clonality was established using the BIOMED-2 IGH framework assays in 5 of 6 fresh or frozen FL specimens. Clonality was established in 15 of 40 FFPE specimens using the BIOMED-2 IGL assay. In contrast, the two BIOMED-2 IGK assays established clonality in 38 of 40 FFPE FL specimens. Sequencing of IGK in serial sections confirmed clonality in 84% of FFPE FL specimens. There was no correlation between maximum PCR product size using the BIOMED specimen control ladder kit and establishment of clonality (p>0.84), but the BIOMED-2 IGH assay tended to have a slightly higher success rate in FFPE specimens for which the 400 bp product could be amplified.

  • Biospecimens

    TissueLymph Node
  • Preservation Types

    FormalinFrozenNone (Fresh)
  • Diagnoses

    NeoplasticLeukemia
    NeoplasticLymphoma
  • Platforms

    DNAPCR
    DNADNA sequencing
  • Pre-analytical Factors

    ClassificationPre-Analytical FactorValue(s)
    PreaquisitionDiagnosis/ patient condition
    Small lymphocytic lymphoma/chronic lymphocytic leukemias
    Follicular lymphoma
    Large B-cell lymphoma
    Biospecimen PreservationType of fixation/preservation
    Formalin (buffered)
    Frozen
    None (fresh)
    PCR SpecificLength of gene fragment
    100 bp
    200 bp
    300 bp
    400 bp
    PCR SpecificTargeted nucleic acid
    Immunoglobin H framework region 1
    Immunoglobin H framework region 2
    Immunoglobin H framework region 3
    Immunoglobin kappa 1
    Immunoglobin kappa 2
    Immunoglobin lambda junctional region
    Immunoglobin lambda variable region
    DNA sequencing SpecificTargeted nucleic acid
    Immunoglobin kappa 1
    Immunoglobin kappa 2